73家企业抱团出海参展，海外买家提前“锁单” 四川生物医药企业赴欧抢抓订单

Core Insights - The participation of Sichuan's biopharmaceutical companies in the 2025 World Pharmaceutical Raw Materials Europe Exhibition marks a significant step towards integrating into the global industrial chain [1][3] - Sichuan's exhibition area exceeds 900 square meters, ranking among the top in China's exhibition groups [2] - The delegation consists of 73 local pharmaceutical and related enterprises, with over 150 participants showcasing key products such as specialty raw materials, high-end medical devices, and innovative biopharmaceuticals [1][2] Industry Overview - The World Pharmaceutical Raw Materials Europe Exhibition is the largest and most influential event in the pharmaceutical industry, attracting over 2,500 exhibitors from more than 140 countries and regions [1][2] - The exhibition focuses on green pharmaceuticals and biomanufacturing, aligning well with the development direction of Sichuan's biopharmaceutical industry [2][3] Company Highlights - Notable companies participating include Sichuan Kelun Pharmaceutical, Chengdu Kanghua Biological Products, and Chengdu Beite Pharmaceutical, covering the entire biopharmaceutical industry chain in Sichuan [3] - Sichuan Xinmeijia Biopharmaceutical Co., Ltd. is the largest fish oil producer in China, with significant orders expected during the exhibition, including a projected 30 million yuan in contracts [4] - Chengdu Okang Pharmaceutical Co., Ltd., listed on the Beijing Stock Exchange, is expanding from health food and food additives into the raw materials market [4] Strategic Goals - The event is part of the "Chuanxing Tianxia" international market expansion initiative, aiming to showcase Sichuan's innovative strength and development vitality in the biopharmaceutical sector [1][3] - The strategy emphasizes building networks and strengthening supply chains to enhance international order acquisition and promote high-quality industry development [4]